A real-world pharmacovigilance study of axitinib: data mining of the public version of FDA adverse event reporting system

阿西替尼 医学 不良事件报告系统 药物警戒 不利影响 四分位间距 优势比 内科学 肾细胞癌 肿瘤科 舒尼替尼
作者
Yamin Shu,Yufeng Ding,Bing Dai,Qilin Zhang
出处
期刊:Expert Opinion on Drug Safety [Taylor & Francis]
卷期号:21 (4): 563-572 被引量:46
标识
DOI:10.1080/14740338.2022.2016696
摘要

Axitinib was approved for treatment of advanced renal cell carcinoma (RCC). The current study was to assess axitinib-related adverse events (AEs) through data mining of the US Food and Drug Administration Adverse Event Reporting System (FAERS).Disproportionality analyses, including the reporting odds ratio (ROR), the proportional reporting ratio (PRR), the Bayesian confidence propagation neural network (BCPNN), and the multi-item gamma Poisson shrinker (MGPS) algorithms, were employed to quantify the signals of axitinib-associated AEs.Out of 10,703,806 reports collected from the FAERS database, 9044 reports of axitinib as the 'primary suspected (PS)' AEs were identified. Axitinib induced AEs occurrence targeted 26 organ systems. A total of 95 significant disproportionality PTs conforming to the four algorithms were simultaneously retained. Rare reports and significant signals of aortic disease have emerged. Unexpected significant AEs such as scrotal swelling, scrotal ulcers, infections, and infestations might also occur. The median onset time of axitinib-associated AEs was 63.5 days (interquartile range [IQR] 20-182 days), and most of the cases occurred within the first one and 2 months after axitinib initiation.Our study found potential new AEs signals and might provide important support for clinical monitoring and risk identification of axitinib.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
DADing发布了新的文献求助20
刚刚
Agoni完成签到,获得积分10
1秒前
丘比特应助myheat采纳,获得10
1秒前
2秒前
2秒前
不安的听寒完成签到 ,获得积分10
2秒前
3秒前
RA000完成签到,获得积分10
3秒前
kulei完成签到,获得积分10
4秒前
彭于晏应助Grace采纳,获得10
4秒前
Never stall发布了新的文献求助10
4秒前
Morpheus完成签到,获得积分10
5秒前
6秒前
贪玩若剑发布了新的文献求助10
6秒前
高高发布了新的文献求助10
6秒前
YYT发布了新的文献求助10
6秒前
CipherSage应助yyd采纳,获得10
6秒前
Minton发布了新的文献求助10
7秒前
TCB发布了新的文献求助10
8秒前
太叔文博完成签到,获得积分0
8秒前
BMH完成签到,获得积分10
8秒前
wljwljwlj完成签到,获得积分10
8秒前
CipherSage应助戒糖采纳,获得10
9秒前
9秒前
上官若男应助zzz采纳,获得10
9秒前
10秒前
10秒前
mao305完成签到,获得积分10
10秒前
千寻完成签到,获得积分10
11秒前
冷静剑鬼发布了新的文献求助10
12秒前
小蜗发布了新的文献求助10
13秒前
13秒前
陈隆发布了新的文献求助10
13秒前
13秒前
14秒前
15秒前
Yu发布了新的文献求助10
15秒前
16秒前
顾矜应助TCB采纳,获得10
16秒前
17秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3970172
求助须知:如何正确求助?哪些是违规求助? 3514982
关于积分的说明 11176568
捐赠科研通 3250212
什么是DOI,文献DOI怎么找? 1795198
邀请新用户注册赠送积分活动 875702
科研通“疑难数据库(出版商)”最低求助积分说明 805004